Prospects of antisense oligodeoxynucleotides to alleviate renal ischaemia-reperfusion injury

Expert Opinion on Biological Therapy

Volumn 4, Issue 12, 2004, Pages 1931-1937

  Matsuyama, Masahide ^a   Yoshimura, Rikio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 lipoxygenase; Acute tubular necrosis; Antisense oligodeoxynucleotide; Cyclooxygenase; Intercellular adhesion molecule 1; NF B; Renal ischaemia reperfusion injury; Tissue factor

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ARACHIDONATE 5 LIPOXYGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PROSTAGLANDIN SYNTHASE;

ACUTE KIDNEY TUBULE NECROSIS; GENE FUNCTION; GENE TARGETING; HEART ARREST; HUMAN; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; REVIEW;

ANIMALS; GENE TARGETING; HUMANS; KIDNEY; KIDNEY DISEASES; OLIGONUCLEOTIDES, ANTISENSE; REPERFUSION INJURY;

EID: 10344225046     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.4.12.1931     Document Type: Review

References (36)

1. OJO AO, WOLFE RA, HELD PJ, PORT FK, SCHMOUDER RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 63(7):968-974.
2. TOMITA N, MORISHITA R: Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases. Curr. Pharm. Des. (2004) 10(7):797-803. An original article on AS-ODNs as a useful therapy for cardiovascular disease.
3. CROOKE ST: Antisense strategies. Curr. Mol. Med. (2004) 4(5):465-487. A thorough review of AS-ODNs.
4. PHILLIPS MI, GALLI SM, MEHTA JL: The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease. Drugs (2000) 60(2):239-248. An original article on AS-ODNs as a useful therapy for cardiovascular disease.
5. MATSUYAMA M, YOSHIMURA R, AKIOKA K et al.: Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury. Transplantation (2003) 76(5):786-791. An original article on antisense-TF as useful for the inhibition of renal I/R injury.
6. DRAGUN D, TULLIUS SG, HALLER H et al.: ICAM-1 antisense oligodesoxynudeotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int. (1998) 54(2):590-602. An original article on antisense-ICAM-1 as useful for the inhibition of renal I/R injury.
7. NAKA Y, ROY DK, SMERLING AJ et al.: Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J. Thorac. Cardiovasc. Surg. (1995) 110(5):1434-1440.
8. CHANG SW, WESTCOTT JY, PICKETT WC, MURPHY RC, VOELKEL NF: Endotoxin-induced lung injury in rats: role of eicosanoids. J. Appl. Physiol. (1989) 66(5):2407-2418.
9. KEAN JM, MURAKAMI A, BLAKE KR, CUSHMAN CD, MILLER PS: Photochemical cross-linking of psoralen-derivatized oligonudeoside methylphosphonates to rabbit globin messenger RNA. Biochemistry (1988) 27(26):9113-9121.
10. SLOOP KW, CAO JX, SIESKY AM et al.: Hepatic and glucagon-like pepode-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J. Clin. Invest. (2004) 113(11):1571-1581.
11. HAYWARD RL, MACPHERSON JS, CUMMINGS J, MONIA BP, SMYTH JF, JODRELL DI: Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect. Mol. Cancer Ther. (2004) 3(2):169-178.
12. YU RZ, GEARY RS, MONTEITH DK et al.: Tissue disposition of 2′-O-(2-methoxy) ethyl modified antisense oligonudeotides in monkeys. Pharm. Sci. (2004) 93(1):48-59.
13. TOMITA N, OGIHARA T, MORISHITA R: Therapeutic potential of decoy oligodeoxynudeotides strategy in cardiovascular diseases. Expert Rev. Cardiovasc. Ther. (2003) 1(3):463-470. An original article on the transfer of cis-element double-stranded ODN as a useful therapy for cardiovascular disease.
14. MORISHITA R, TOMITA N, KANEDA Y, OGIHARA T: Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Curr. Opin. Pharmacol. (2004) 4(2):139-146. A thorough review on the transfer of cis-element double-stranded ODNs.
15. KOBAYASHI Y, YOSHIMURA N, NAKAMURA K, YAMAGISHI H, OKA T: Expression of tissue factor in hepatic ischemic-reperfusion injury of the rat. Transplantation (1998) 66(6):708-716.
16. YOSHIMURA N, KOBAYASHI Y, NAKAMURA K, YAMAGISHI H, OKA T: The effect of tissue factor pathway inhibitor on hepatic ischemic reperfusion injury of the rat. Transplantation (1999) 67(1):45-53.
17. USHIGOME H, YOSHIMURA N, SANO H, NAKAMURA K, OKA T: Expression of tissue factor in renal ischemic-reperfusion injury of the rat. Transplant. Proc. (1998) 30(7)3764-3765.
18. NAKAMURA K, OKAMOTO M, AKIOKA K et al.: Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury. Transplant. Proc. (2001) 33(7-8):3707-3708.
19. USHIGOME H, SANO H, OKAMOTO M et al.: The role of tissue factor in renal ischemic reperfusion injury of the rat. J. Surg. Res. (2002) 102:102-109.
20. MATSUYAMA M, AKIOKA K, OKAMOTO M et al.: The role of tissue factor in renal ischemic reperfusion injury by antisense oligonudeotide. Transplant. Proc. (2002) 34(5):1475-1476.
21. MATSUYAMA M, AKIOKA K, OKAMOTO M et al.: Control of renal ischemic reperfusion injury by antisense oligodeoxynucleotide of tissue factor. Transplant. Proc. (2003) 35(1):103-104.
22. NAKAMURA K, KADOTANI Y, USHIGOME H et al.: Antisense oligonudeotide for tissue factor inhibits hepatic ischemic reperfusion injury. Biochem. Biophys. Res. Commun. (2002) 297(3):433-441. An original article on antisense-TF as useful for the inhibition of hepatic I/R injury.
23. STEPKOWSKI SM, WANG ME, CONDON TP et al.: Protection against allograft rejection with intercellular adhesion molecule-1 antisense E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet oligodeoxynucleotides. Transplantation (1998) 66(6): 699-707. An original article on AS-ODNs as a useful therapy for renal transplantation.
24. STEPKOWSKI SM: Development of antisense oligodeoxynucleotides for transplantation. Curr. Opin. Mol. Ther. (2000) 2(3):304-317. A thorough review on AS-ODNs as a useful therapy for renal transplantation.
25. SCHMID E, MULLER TH, BUDZINSKI RM, BINDER K, PFIZENMAIER K: Signaling by E-selectin and ICAM-1 induces endotheliat tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J. Interferon Cytokine Res. (1995) 15(9):819-825.
26. KELLY KJ, WILLIAMS WW, COLVIN RB et al.: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J. Clin. Invest. (1996) 97(4):1056-1063.
27. KELLY KJ, WILLIAMS WW, COLVIN RB, BONVENTRE JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA (1994) 91(2):812-816.
28. LOPEZ-NEBLINA F, PAEZ-ROLLYS AJ, TOLEDO-PEREYRA LH: Mechanism of protection of verapamil by preventing neutrophil infiltration in the ischemic rat kidney. J. Surg. Res. (1996) 61 (2):469-472.
29. BANAFSCHE R, GUNTHER L, NEFFLEN JU et al.: NF-kappa B antisense oligonudeotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperrusion. Transplant. Proc. (2001) 33(7-8):3726-3727.
30. TAKEYOSHI I, SUNOSE Y, IWAZAKI S et al.: The effect of a selective cyclooxygenase-2 inhibitor in extended liver resection with ischemia in dogs. J. Surg. Res. (2001) 100(1):25-31.
31. SUNOSE Y, TAKEYOSHI I, TSUTSUMI H et al.: Effects of FK3311 on pulmonary ischemia-reperfusion injury in a canine model. J. Surg. Res. (2001) 95(2):167-173.
32. MATSUYAMA M, NAKATANI T, KAWAHITO Y et al.: The expression of cyclooxygenases (COXs) and lipoxygenases (LOXs) in renal ischemia-reperfusion injury. Transplant. Proc. (2004) 36(7):1939-1942.
33. YAMADA R, SANO H, HLA T et al.: Selective inhibition of cyclooxygenase-2 with antisense oligodeoxynucleotide restricts induction of rat adjuvant-induced arthritis. Biochem. Biophys. Res. Commun. (2000) 269(2):415-421.
34. HASHIMOTO H, MIYAZAWA K, HAGIWARA M, MIYASAKA K, NAKASHIMA M: Benefical effects of a 5-lipoxygenase inhibitor on occlusion-and occlusion-reperfusion- induced myocardial injury. Arzneimittelforshung (1990) 40(2):126-129.
35. SHISHIDO Y, FURUSHIRO M, HASHIMOTO S, YOKOKURA T: Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after fbrebrain ischemia. Pharmacol. Biochem. Behav. (2001) 69(3-4):469-474.
36. PATEL NS, CUZZOCREA S, CHATTERJEE PK et al.: Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol. Pharmacol. (2004) 66(2):220-227.